Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 2:15:663092.
doi: 10.3389/fncel.2021.663092. eCollection 2021.

Mechanisms of Invasion in Glioblastoma: Extracellular Matrix, Ca2+ Signaling, and Glutamate

Affiliations
Review

Mechanisms of Invasion in Glioblastoma: Extracellular Matrix, Ca2+ Signaling, and Glutamate

Jae-Seon So et al. Front Cell Neurosci. .

Abstract

Glioblastoma (GBM) is the most common and malignant form of primary brain tumor with a median survival time of 14-16 months in GBM patients. Surgical treatment with chemotherapy and radiotherapy may help increase survival by removing GBM from the brain. However, complete surgical resection to eliminate GBM is almost impossible due to its high invasiveness. When GBM cells migrate to the brain, they interact with various cells, including astrocytes, neurons, endothelial cells, and the extracellular matrix (ECM). They can also make their cell body shrink to infiltrate into narrow spaces in the brain; thereby, they can invade regions of the brain and escape from surgery. Brain tumor cells create an appropriate microenvironment for migration and invasion by modifying and degrading the ECM. During those processes, the Ca2+ signaling pathway and other signaling cascades mediated by various ion channels contribute mainly to gene expression, motility, and invasion of GBM cells. Furthermore, GBM cells release glutamate, affecting migration via activation of ionotropic glutamate receptors in an autocrine manner. This review focuses on the cellular mechanisms of glioblastoma invasion and motility related to ECM, Ca2+ signaling, and glutamate. Finally, we discuss possible therapeutic interventions to inhibit invasion by GBM cells.

Keywords: Ca2+; extracellular matrix; glioblastoma; glutamate; invasion; ion channels.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
ECM, Ca2+ signaling, and glutamate mediates invasion and migration in glioma cells. (A) Extracellular matrix and their binding partners regulate invasion and motility in GBM cells. (B) Intracellular Ca2+ elevation from ER and extracellular region affects glioma cell migration and invasion. Ca2+ influx through TRP channels, P2 × 7Rs, and t-type Ca2+ channels are critically involved in glioma cell infiltration. (C) Glioma cells release glutamate through a cysteine-glutamate exchanger (system xC). Released glutamate from glioma cells activates Ca2+-permeable AMPARs and NMDARs and affects migration and invasion. Sustained Ca2+ influx causes excitotoxic death of surrounding cells to make microenvironment for invasion.
FIGURE 2
FIGURE 2
Schematic linking mechanisms of ECM, Ca2+ signaling, and glutamate in GBM invasion. Summary of mechanisms of glioma invasion related to ECM, Ca2+ signaling, and glutamate. Glutamate release from GBM cells activates Ca2+ permeable AMPARs and NMDARs in an autocrine manner, thereby cause an intracellular Ca2+ increase in GBM cells. ECM and their binding partners affect GBM invasion by regulating Ca2+ signaling.

References

    1. Akiyama Y., Jung S., Salhia B., Lee S., Hubbard S., Taylor M., et al. (2001). Hyaluronate receptors mediating glioma cell migration and proliferation. J. Neurooncol. 53 115–127. - PubMed
    1. Almiron Bonnin D. A., Havrda M. C., Israel M. A. (2018). Glioma Cell secretion: a driver of tumor progression and a potential therapeutic target. Cancer Res. 78 6031–6039. 10.1158/0008-5472.can-18-0345 - DOI - PubMed
    1. Alptekin M., Eroglu S., Tutar E., Sencan S., Geyik M. A., Ulasli M., et al. (2015). Gene expressions of TRP channels in glioblastoma multiforme and relation with survival. Tumour Biol. 36 9209–9213. 10.1007/s13277-015-3577-x - DOI - PubMed
    1. Amorim S., Reis C. A., Reis R. L., Pires R. A. (2021). Extracellular matrix mimics using hyaluronan-based biomaterials. Trends Biotechnol. 39 90–104. 10.1016/j.tibtech.2020.06.003 - DOI - PubMed
    1. Angel I., Pilo Kerman O., Rousso-Noori L., Friedmann-Morvinski D. (2020). Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma. Oncogene 39 6990–7004. 10.1038/s41388-020-01506-6 - DOI - PubMed